Then they and science should change their sensationalist headline. It's ironic that a paper about fakeness of something uses a borderline misleading title.
Simply reading a title and on a topic you don’t find interesting then gives people the wrong impression.
They better have a flawless methodology, because any tiny problem is enough to ruin their analysis. And well, just flagging almost any paper not from the EU or US as fraud doesn't usually come together with a flawless methodology.
I think this paper by Peter J Diggle [0], gives a solid methodology. Instead of treating sensitivity and specificity as fixed values using sample estimates, you can model them as each having a beta distribution. In this case these beta distributions can be found using a Bayesian treatment of Bernoulli trials.
[0] https://github.com/indralab/opaque/blob/761572ed1b0d601271f0...
Perhaps any paper without error bars should be tagged as a fake paper.
This one would have sneaked past though: https://retractionwatch.com/2022/12/05/a-paper-used-capital-...
A completely random test given equal populations results in 50% accuracy and 50% specificity. Things don’t look nearly as good if only 1% of the actual population has the condition.
If you know the true prevalence of a disease in a population, and the sensitivity and specificity of your test, you can predict how many positive measurements you obtain. Vice versa, from the (flawed raw) measurement, given sensitivity and specificity, you can estimate the true prevalence.
Furthermore, they’re explicitly saying that “red flagging” by their simple indicator doesn’t mean that the paper is fake, but that it merits higher scrutiny.
ETA: I mean, it could still all be bullshit (by virtue of some bias or so), but you’ll need to argue a bit harder to establish that.